期刊文献+

高效液相色谱梯度洗脱法测定大鼠胆汁中9-硝基喜树碱含量 被引量:9

Determination of 9-nitrocamptothecin in the rat′s bile by HPLC using the gradient elution
下载PDF
导出
摘要 目的建立大鼠胆汁中 9 硝基喜树碱的高效液相色谱梯度洗脱方法。方法胆汁样品经乙腈 水 ( 1∶1 )稀释后 ,直接进样。检测波长为 370nm ,采用HypersilBDSC18柱 ( 5 μm,1 5 0mm× 4 6mmI D )分离 ,使用以乙腈 2 %甲酸水溶液为流动相的二元梯度洗脱方法。结果线性范围为 0 5~2 5 μg/mL,定量限为 0 5 μg/mL。结论本法操作简便 ,成功应用于胆汁中 9 硝基喜树碱的含量的测定及胆汁中 9 硝基喜树碱代谢物的初步研究。 Objective To develop a novel HPLC UV method for determination of 9 nitrocamptothecin (9 NC) in the rat′s bile. Method The samples were separated on a Hypersil BDS C 18 column after being diluted by acetonitrile water (1∶1). The mobile phase consisted of acetonitrile and water, and a gradient elution program was applied. The UV detector was set at 370 nm. Result The liner calibration curves were obtained in the concentration range of 0 5 ~ 25 μg/mL . The limit of quantification was 0 5 μg/mL . Conclusion The method was simple and successfully applied to determining the concentrations of 9 NC in the bile samples, and it also offered a way to the preliminary study on the metabolites of 9 NC in the rat′s bile.
出处 《沈阳药科大学学报》 CAS CSCD 2002年第2期101-104,共4页 Journal of Shenyang Pharmaceutical University
基金 国家自然科学基金资助项目 ( 39930 1 80 )
关键词 9-硝基喜树碱 高效液相色谱法 梯度洗脱 胆汁 大鼠 含量 抗癌药 nitrocamptothecin HPLC gradient elution bile
  • 相关文献

参考文献4

  • 1Verschraegen CF, Natelson EA, Giovanella BC, et al. A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor [J]. Anti-Cancer Drugs, 1998,9:36-44.
  • 2Hinz HR, Harris NJ, Natelson EA, et al. Pharmacokinetics of the in vivo and in vitro conversion of 9-amino-20(S)-camptothecin in humans, dog, and mice [J]. Cancer Res, 1994,54:3096-3100.
  • 3Shah VP, Midha KK, Dighe S, et al. Analytical method validation:bioavailability, bioequivalence and pharmacokinetic studies [J]. J Pharm Sci, 1992,81(3):309-312.
  • 4Loos WJ, Bruijn PD, Verweij J, et al. Determination of camptothecin analogs in biological matrices by high-performance liquid chromatography [J]. Anti-Cancer Drugs, 2000,11:315-324.

同被引文献110

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部